JHJayandra Jung Himali

Jayandra Jung Himali

*This is an algorithmically generated author record based on publicly available information.

Jayandra Jung Himali has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex-Specific Machine Learning–Enabled Risk Prediction for Dementia Using Cardiovascular Risk Factors

    by Jingzhi Yu, John Stephen, Lucia C. Petito, Abigail Gauen, Lihui Zhao, Maxwell Mansolf, Elizabeth A. Peterson, Rachel Zmora, Denise Scholtens, Katherine Giorgio, et al.

    Background and ObjectivesDementia remains without curative treatments, underscoring the need for early identification of high-risk individuals. There may be sex-specific differences in associations...

  • Association of Sleep Variables With Cognitive Performance and the Risk of Dementia in the Sleep and Dementia Consortium

    by Stephanie Yiallourou, Crystal Wiedner, Qiong Yang, Andrée-Ann Baril, Jeffrey R. Misialek, Christopher E. Kline, Stephanie Harrison, Rebecca Bernal, Alycia Bisson, Dibya Himali, et al.

    Background and ObjectivesSleep is multidimensional, and it remains unclear which aspects are most relevant to cognition and dementia risk. We aimed to apply a data-driven approach to identify clust...

  • Open Access

    The Association Between APOE Genotype, Race, and Dementia

    by Natalia Lakomski, Katherine Giorgio, John Stephen, Maxwell Mansolf, Aïcha Soumaré, Alden L. Gross, Allison E. Aiello, Archana Singh-Manoux, M. Arfan Ikram, Catherine Helmer, et al.

    Background and ObjectivesThe apolipoprotein E (APOE) haplotypes are known to be associated with dementia, with the ε4 haplotype associated with higher risk. It has been suggested that the APOE ε2 a...


  • Association of an Aquaporin-4 Haplotype With Cognition, Brain Volume, and Dementia Risk in Community-Dwelling Individuals Without Dementia

    by Emma Louise Palatsides, Dibya Himali, Lachlan Cribb, Gina M. Peloso, Joanne Ryan, Qiong Yang, Charles S. Decarli, Alexa S. Beiser, Sudha Seshadri, Marina G. Cavuoto, et al.

    Background and ObjectivesThe aquaporin-4 (AQP4) water channel plays an integral role in clearing brain waste. However, little is known about whether variations in the AQP4 gene contributes to brain...


  • Open Access

    Hearing loss in the young-old is associated with increased risk for Alzheimer's disease and vascular dementia

    by Lily Francis, Alexa Beiser, Sophia Lu, Sharon G Kujawa, Nancy Heard-Costa, Francis B Kolo, M Ilyas Kamboh, Rebecca Bernal, D Bradley Welling, Richard L Alcabes, et al.

    Hearing loss is a risk factor for dementia, but dementia subtypes underlying this association and effect modifiers are unknown. Using data collected from 2000 Framingham Heart Study participants we found that hearing loss increases risk for Alzheimer's disease and vascular dementia in participants aged 60–70 years (“young-old”) at time of hearing assessment (Alzheimer's disease: HR 1.46[CI 1.07–2.0] p = 0.017; vascular dementia: HR 2.08[CI 1.22–3.56] p = 0.007). Longer duration of hearing loss determines increased risk for Alzheimer's disease and vascular dementia, and screening and intervention for hearing loss from mid-life may help reduce dementia.


  • Open Access

    Lifelong trajectories of modifiable vascular risk factors and relation to cerebral small vessel disease in the Framingham Heart Study

    by Jose R. Romero, Adlin Pinheiro, Serkalem Demissie, Hugo J. Aparicio, Vasileios-Arsenios Lioutas, Antreas Charidimou, Alexa Beiser, Oluchi Ekenze, Jayandra J. Himali, Charles DeCarli, et al.

    Background: Cerebral small vessel disease (CSVD) is strongly linked to stroke and dementia risk, frequently predating clinical events for years to decades. Preventive efforts focus on treatment of modifiable vascular risk factors (VRF), but the complex changes in VRF over long periods in relation to CSVD burden remain unclear. Thus, we aimed to characterize life-long VRF trajectories in community-dwelling individuals and relate them to CSVD burden. Methods: Framingham Heart Study participants from the Original and Offspring cohorts with six or more repeated VRF assessments over their lifetime were eligible for the present study. Among those who underwent MRI imaging, CSVD burden was quantified by assigning one point each for cerebral microbleeds, covert infarcts, extensive white matter hyperintensities, cortical superficial siderosis, and high perivascular space burden (range: 0–5). VRF trajectories and trajectory-based clusters were then examined in relation to CSVD burden using functional regression analysis. Results: Of 7,961 participants with longitudinal VRF measurements (mean baseline age 39.8 ± 10 years, 45% men), 1,625 underwent MRI imaging after exclusions for other neurological conditions. In models that used individual VRF trajectories as covariates, systolic and diastolic blood pressure, pulse pressure, cigarettes per day and triglycerides were significantly associated with CSVD burden later in life. In a complementary analysis, we clustered VRF trajectories and then used each participant’s cluster assignment (rather than the raw trajectories) as the covariate; cluster assignments diverged early in life for systolic blood pressure and pulse pressure and were significantly associated with CSVD burden. Conclusions: Individuals following high risk lifetime patterns of vascular risk factors have higher CSVD burden later in life. These results highlight the importance of primordial and primary prevention with sustained risk factor management across the lifespan to mitigate CSVD burden, a strong determinant of stroke and dementia risk.

  • Open Access

    A data driven approach to assess relationships between sleep, cognition and dementia: Findings from the Sleep and Dementia Consortium

    by Stephanie Yiallourou, Crystal Wiedner, Qiong Yang, Andree-Ann Baril, Jeffrey R. Misialek, Christopher E. Kline, Stephanie Harrison, Rebecca Bernal, Alycia Bisson, Dibya Himali, et al.

    Background and Objectives: Sleep has been associated with cognition and risk of dementia. However, sleep is a highly complex and multi-dimensional state, and there is uncertainty about which aspects of sleep are most relevant to cognitive performance and dementia risk. We applied a data-driven approach to identify clusters of sleep variables that reflect meaningful sleep composites and examined their association with cognitive performance and dementia risk. Methods: Data from the Sleep and Dementia Consortium, consisting of 5 US population-based cohorts were utilized. Participants had methodologically consistent, home-based polysomnography, self-report habitual sleep, neuropsychological assessments, and dementia risk surveillance. The pooled cognitive analysis included 5,958 participants aged ≥45 years, and the incident dementia analysis included 5,471 participants aged ≥60 years. A cluster around latent variables analysis was used to derive 9 latent sleep composites from 44 sleep metrics. Global cognitive composite z-scores were derived from principal component analysis. Linear regression models were used to assess associations between sleep composites and cognitive performance. Cox proportional hazard models assessed associations between sleep composites and incident dementia. Results: Mean (SD) age was 70 ± 11 and 74 ± 12 years for the cognitive and dementia analysis, respectively. There were 1,134 incident dementia cases (median follow-up time of 5-19 years). 9 sleep composites were identified, together explaining 49% of the total variance in the original 44 sleep metrics: Sleep quantity and efficiency, sleep fragmentation, light NREM predominance, N3 predominance, spindle number and duration, REM sleep bouts, respiratory disturbances, slow oscillation-spindle coupling and spindle amplitude. Of these, composites reflecting greater sleep quantity and efficiency (i.e., longer and more consolidated sleep; pooled β per one-unit change in composite, 0.03; 95% CI: 0.004 - 0.06; p=0.033) and stronger slow oscillation-spindle coupling (pooled β, 0.04; 95% CI: 0.003 - 0.07; p=0.039) were associated with better global cognition. However, no significant associations were identified between the 9 sleep composites and dementia risk. Discussion: Our data-driven approach identified longer, more consolidated sleep and stronger slow oscillation-spindle coupling as the composites of sleep most strongly related to cognitive performance. These composites may be useful in guiding further investigations of sleep-brain health relationships.

  • Association of MRI-Visible Perivascular Spaces and Incident Depression in the Framingham Heart Study

    by Sara Medved, Adlin Pinheiro, Pedram Parva, Andreas Charidimou, Jayandra J. Himali, Charles S. Decarli, Alexa S. Beiser, Sudha Seshadri, Serkalem Demissie, Jose Rafael Romero


  • Open Access

    Long‐Term Incidence of Dementia Following Transient Ischemic Attack: A Longitudinal Cohort Study

    by Vasileios‐Arsenios Lioutas, Gina Peloso, Jose Rafael Romero, Hugo Aparicio, Mitzi Gonzales, Amy Werry, Dibya Himali, Jayandra Himali, Ayantika Banerjee, Saptaparni Gosh, et al.

    Background: The association between transient ischemic attack (TIA) and dementia is incompletely characterized. Determining the cognitive sequalae of TIA is important as it can function as an early warning sign or additional risk factor for dementia. We sought to determine the long‐term incidence of post‐TIA dementia and examined whether TIA prompts changes in vascular risk factors. Methods: Nested matched longitudinal cohort study within the community‐based Framingham Heart Study. A prospectively collected sample of participants without dementia or transient ischemic attack were matched on age and sex (5:1) to participants with first incident TIA >60 years. The primary outcome of interest was the 20‐year incidence of all‐cause dementia. Results: The study matched 297 participants with TIA, 141 (47%) men, mean age 72.7±7.7 years, with 1485 controls without TIA. People with TIA were more likely to have hypertension, coronary heart disease, and atrial fibrillation. Over a median of 8.9 years of follow up, 57 (19%) participants with TIA and 353 (24%) controls without TIA developed dementia (hazard ratio [HR], 0.93 [95% CI, 0.71–1.24], P =0.63). Adjusting for stroke and accounting for the competing risk of death did not alter this association. Participants with TIA were more likely to have a reduction in the frequency of smoking (18% to 11%, P =0.025), an increase in anticoagulant use from 3% to 18%, ( P =0.0005), and a marginal increase in aspirin use (46% to 61%, P =0.052). Conclusions: We found no significant difference in dementia incidence over a 20‐year follow‐up period compared with matched TIA‐free controls. Our findings suggest that TIA prompts treatment changes and behavioral shifts that lower cardiovascular risk. Whether these are sufficient to mitigate subsequent dementia risk remains to be tested in prospective randomized studies.


  • Open Access

    Late-life sleep medication use associated with increased falls risk in the Atherosclerosis Risk in Communities (ARIC) study

    by Kelsie M. Full, Snigdha S. Pusalavidyasagar, Priya Palta, Caitlin W. Hicks, Adam P. Spira, Beverly Gwen Windham, Stephen P. Juraschek, Matthew P. Pase, Jayandra J. Himali, Pamela L. Lutsey